Allspring Global Investments Holdings, LLC Icosavax, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$5.95 - $15.79 $31,416 - $83,371	5,280 Added 39.32%	18,708 $294,000
Q3 2023 Oct 27, 2023	BUY	$7.22 - $10.05 $96,950 - $134,951	13,428 New	13,428 $104,000
Q2 2023 Jul 18, 2023	SELL	$4.89 - $10.57 $12,141 - $26,245	-2,483 Reduced 15.48%	13,562 $134,000
Q1 2023 Apr 13, 2023	SELL	$5.62 - $11.51 $938 - $1,922	-167 Reduced 1.03%	16,045 $93,000
Q4 2022 Jan 23, 2023	SELL	$2.32 - $10.97 $14,685 - $69,440	-6,330 Reduced 28.08%	16,212 $0
Q3 2022 Oct 26, 2022	SELL	$3.09 - $9.21 $14,828 - $44,198	-4,799 Reduced 17.55%	22,542 $71,000
Q2 2022 Jul 25, 2022	BUY	$5.7 - $10.33 $103,170 - $186,973	18,100 Added 195.87%	27,341 $156,000
Q1 2022 May 02, 2022	BUY	$4.41 - $22.5 $13,966 - $71,257	3,167 Added 52.14%	9,241 $65,000
Q4 2021 Jan 28, 2022	BUY	$21.07 - $34.98 $127,979 - $212,468	6,074 New	6,074 $138,000

Others Institutions Holding ICVX

# of Institutions

Shares Held

1.37M

Call Options Held

Put Options Held

View Full List

About Icosavax, Inc.

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

More about ICVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account